Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Depreciation & Amortization (CF) (2020 - 2025)

LifeStance Health (LFST) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $13.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 8.43% to $13.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $54.8 million, a 22.83% decrease, with the full-year FY2025 number at $54.8 million, down 22.83% from a year prior.
  • Depreciation & Amortization (CF) was $13.4 million for Q4 2025 at LifeStance Health, down from $13.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $22.6 million in Q1 2024 to a low of $12.2 million in Q1 2021.
  • A 5-year average of $16.8 million and a median of $16.2 million in 2022 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): increased 28.26% in 2022, then tumbled 39.04% in 2025.
  • LifeStance Health's Depreciation & Amortization (CF) stood at $15.4 million in 2021, then increased by 22.99% to $18.9 million in 2022, then grew by 17.63% to $22.2 million in 2023, then tumbled by 33.96% to $14.7 million in 2024, then decreased by 8.43% to $13.4 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Depreciation & Amortization (CF) are $13.4 million (Q4 2025), $13.6 million (Q3 2025), and $14.0 million (Q2 2025).